1-O-[4-O-(3-O-α-ノイラミノシル-β-D-ガラクトピラノシル)-β-D-グルコピラノシル]セラミド

危険有害性情報のコード(GHS)

• 絵表示(GHS)

  

• 注意喚起語

  Warning

1-O-[4-O-(3-O-α-ノイラミノシル-β-D-ガラクトピラノシル)-β-D-グルコピラノシル]セラミド 価格

1-O-[4-O-(3-O-α-ノイラミノシル-β-D-ガラクトピラノシル)-β-D-グルコピラノシル]セラミド 化学特性,用途語,生産方法

• 使用

  Monosialoganglioside GM3 can have anti-tumor effects by regulating cell apoptosis, angiogenesis. Monosialoganglioside GM3 can also regulate peripheral insulin receptor signaling and increases in GM3 in adipose tissue of obese humans may contribute to insulin resistance.

• 一般的な説明

  Gangliosides are major constituents of neuronal cell membranes and endoplasmic reticulum. They contain a sialated polysaccharide chain linked to ceramide through a β-glycosidic linkage. For classification of gangliosides see Svennerholm, L., et al. (eds.), Structure and Function of Gangliosides, New York, Plenum, 1980.

• Biochem/physiol Actions

  Monosialoganglioside GM3 has a potential role in cancer development and progression. Increased expression of GM3 has been observed in various types of cancer. Hence, it is used as a tumor-associated carbohydrate antigen during cancer vaccine development.

1-O-[4-O-(3-O-α-ノイラミノシル-β-D-ガラクトピラノシル)-β-D-グルコピラノシル]セラミド 生産企業

Global(63)Suppliers

54827-14-4, 1-O-[4-O-(3-O-α-ノイラミノシル-β-D-ガラクトピラノシル)-β-D-グルコピラノシル]セラミド キーワード